Hormonal factors in female sexual dysfunction.

Area of Science:

• Endocrinology
• Sexual Medicine
• Women's Health

Background:

• Female sexual dysfunction (FSD) is a prevalent condition affecting quality of life, mood, and relationships.
• Hormonal imbalances, particularly involving androgens and estrogens, are implicated in FSD, especially sexual arousal disorder and decreased libido.
• The use of androgens for treating decreased libido in postmenopausal women is gaining traction, but research is hampered by inconsistent definitions and assay variability.

Purpose of the Study:

• To review the established roles of estrogen and androgens in female sexual function.
• To evaluate the potential of estrogen and androgen therapy for managing FSD, including decreased libido and sexual arousal disorder.

Main Methods:

• Literature review of existing studies on hormonal influences on female sexual function.
• Analysis of research on androgen and estrogen therapies for FSD.
• Examination of challenges in defining androgen deficiency and interpreting assay results.

Main Results:

• Estrogen and androgens play significant roles in maintaining female sexual function.
• Evidence for androgen therapy in FSD is preliminary and controversial, with challenges in standardization and interpretation.
• Further research is needed to clarify optimal therapeutic strategies.

Conclusions:

• Estrogen and androgens are critical for female sexual health.
• Androgen therapy for FSD shows potential but requires more rigorous research due to existing ambiguities.
• Clarifying diagnostic criteria and standardizing assays are essential for advancing therapeutic options for FSD.